Dr. Speyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 34th St
New York, NY 10016Phone+1 212-731-5165Fax+1 212-731-5342
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1977 - 1979
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1974 - 1976
Johns Hopkins University School of MedicineClass of 1974
Certifications & Licensure
NY State Medical License 1975 - 2024
MD State Medical License 1974 - 1983- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 43 citationsA phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breas...Komal Jhaveri, Rui Wang, Eleonora Teplinsky, Sarat Chandarlapaty, David B. Solit
Breast Cancer Research. 2017-08-02 - 15 citationsSerial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.Maryann Kwa, Xiaochun Li, Yelena Novik, Ruth Oratz, Komal Jhaveri
Breast Cancer Research and Treatment. 2018-02-01 - 9 citationsIntraperitoneal carboplatin: rationale and experience.James L. Speyer, Joan Sorich
Seminars in Oncology. 1992-02-01
Press Mentions
SHARE Friends and Supporters Gather at Tiro A SegnoMarch 30th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
